Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

Research supporting the amyloid hypothesis—the idea that Alzheimer's is caused by a buildup of amyloid plaques in the ...

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...

Charles Piller, author of the new book Doctored, says the scientific community needs “to take a good hard look in the mirror.

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Able to cross the blood-brain barrier, Xenon gas seemed to perk the mice right up, which began to become particularly active ...

In a novel theory, scientists at Arizona State University's Biodesign Institute propose a unifying explanation for the ...

There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...

Annovis Bio has commenced the treatment of subjects in a Phase III clinical trial of buntanetap in treating early Alzheimer's ...

Cure Alzheimer's Fund, a nonprofit dedicated to advancing research with the highest potential to prevent, slow or reverse Alzheimer's disease, announced today that Mary Greenhill Cagliero ...

A research team from the Institut de Neurociències of the Universitat Autònoma de Barcelona (INc-UAB) has discovered that the ...